Takeda Receives Positive Chmp Opinion Recommending Approval Of Dengue Vaccine Candidate In Eu And Dengue-Endemic Countries
Tak-003 Recommended For The Prevention Of Dengue Disease Caused By Any Dengue Virus Serotype In Individuals Four Years Of Age And Older In The Eu And In Dengue-Endemic Countries Participating In The Eu-M4All ProcedurePositive Opinion For Tak-003 Based On 4.5 Years Of Safety And Efficacy Data From Pivotal Phase 3 Trial Of Over 20,000 Children And Adolescents Across Eight Dengue-Endemic CountriesMarketing Authorization Expected In Coming Months In Europe Followed By Regulatory Decisions In Latin America And Asia Takeda Today Announced That The Committee For Medicinal Products For Human Use (Chmp) Of The European Medicines Agency (Ema) Recommended The Approval Of Takeda
Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!
